Michael Sen
Michael Sen is the CEO of Fresenius, a leading global healthcare group, who has significantly influenced the company's performance since his appointment in October 2022. Under his leadership, Fresenius' stock has soared by 73%, reflecting his strategic focus on reducing debt and enhancing operational efficiency. Sen has emphasized a commitment to sustainable growth, particularly in the biopharmaceutical sector, while also managing the complexities of the company's restructuring efforts.
Not in the pool (under ¢1).
Recent news mentions
Michael Sen is the director general of Fresenius who had his contract renewed for five more years.
La matriz alemana de Quirónsalud celebra que su negocio en España crece un 11%, tras un pago de casi 500 millones del Gobierno de Ayuso | Noticias de Madrid
Spain· 2026-02-26
Michael Sen is the CEO of Fresenius and has initiated the 'Future Fresenius' program to revitalize the company.
Fresenius und Digitalisierung im deutschen Gesundheitswesen - Wirtschaft
Germany· 2025-11-19
Michael Sen is the CEO of Fresenius and is praised for leading the company well.
Bessere Value-Opportunitäten ausserhalb der USA
Switzerland· 2025-07-02
Michael Sen has been the CEO of Fresenius since October 2022 and has significantly increased the company's stock price.
Fresenius etabliert sich als solider GesundheitswertSwitzerland· 2025-02-26